Latest news

Pancreatic Cancer UK is today revealing its new brand identity, which will help the charity transform the future for patients and families over the next five years.

Researchers have reclassified pancreatic cancer as four distinct types, a discovery that could offer new opportunities to treat the disease, according to their study published in Nature. 

Pancreatic cancer cases up a third to 12,000 a year by 2030, just 600 of those patients set to live 5 years.

The National Institute of Health and Care Excellence (NICE) has announced it will be assessing a new drug that might offer benefit to some pancreatic cancer patients.

A new National Cancer Advisory Group has recently been set up, tasked with advising the NHS and others on implementing the new Strategy, and are looking for two patient representatives to offer their experience of treatment and care to the Group.